MNMD – mind medicine (mindmed) inc. - common shares (US:NASDAQ)
Stock Stats
News
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its price target lowered by analysts at Robert W. Baird from $27.00 to $16.00. They now have an "outperform" rating on the stock.
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
MindMed to Present at Leerink’s Global Healthcare Conference 2025
MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
Form 10-K Mind Medicine (MindMed) For: Dec 31
Form 8-K Mind Medicine (MindMed) For: Mar 06
Form SCHEDULE 13G/A Mind Medicine (MindMed) Filed by: BlackRock, Inc.
Form 8-K Mind Medicine (MindMed) For: Jan 30
Form 8-K Mind Medicine (MindMed) For: Jan 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.